Justino, M. C. A., Araújo, E. d. C., Doorn, L. V., Oliveira, C. S. d., Gabbay, Y. B., Mascarenhas, J. D. P., . . . Linhares, A. d. C. (2012). Oral live attenuated rotavirus vaccine (RotarixTM) offers a sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.
Referência de acordo com a norma ChicagoJustino, Maria Cleonice Aguiar, et al. Oral Live Attenuated Rotavirus Vaccine (RotarixTM) Offers a Sustained High Protection against Severe G9P[8] Rotavirus Gastroenteritis During the First Two Years of Life in Brazilian Children. 2012.
Referência de acordo com a norma MLAJustino, Maria Cleonice Aguiar, et al. Oral Live Attenuated Rotavirus Vaccine (RotarixTM) Offers a Sustained High Protection against Severe G9P[8] Rotavirus Gastroenteritis During the First Two Years of Life in Brazilian Children. 2012.